Immunosuppression: the tightrope between rejection and infection
After a transplant, your body wants to kill the new organ. So you take immunosuppressive drugs — but they make you vulnerable to infections and cancer. The US transplantation market forecast shows that the immunosuppression market is $2 billion and growing, driven by newer drugs with fewer side effects. Tacrolimus, mycophenolate, and steroids are the backbone.
What's new?...
0 Поделились
183 Просмотры